-
Advancing Type 1 Diabetes Care: Mozart Therapeutics Shares New Data on MTX-101
A New Frontier in Autoimmune Research At the 62nd EASD Annual Meeting, Mozart Therapeutics took center stage to share critical updates regarding their lead therapeutic candidate, MTX-101. This presentation marks an important milestone for the company as they continue to investigate novel ways to treat autoimmune diseases, specifically focusing on Type 1 Diabetes (T1D). Understanding…
-
Sinocare Unveils Integrated Chronic Disease Management Solutions at EASD 2024
Innovation at the Heart of Chronic Care At this year’s EASD (European Association for the Study of Diabetes) annual meeting, Sinocare took center stage to showcase its latest advancements in integrated chronic disease management. As global healthcare shifts toward more patient-centric models, Sinocare is positioning itself as a leader in digital health transformation. Integrated Solutions…